RBGLY INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Reckitt Benckiser Group plc

Reckitt Benckiser securities reminder

The law firm of Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Reckitt Benckiser Group plc (“RB Group” or the “Company”) (OTC BB: RBGLY) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

OMCL INVESTORS ALERT:  Lieff Cabraser Announces Securities Class Action Against Omnicell, Inc.

Omnicell Securities

The law firm of Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Omnicell Inc. (“Omnicell” or the “Company”) (NASDAQ: OMCL)  between October 25, 2018 and July 11, 2019, inclusive (the “Class Period”). [Read more…]

RBGLY INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Reckitt Benckiser Group plc

The law firm of Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased the American Depositary Shares (“ADSs”) of Reckitt Benckiser Group plc (“RB Group” or the “Company”) (OTC BB: RBGLY) between July 28, 2014 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

AOS INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against A.O. Smith Corporation

A.O. Smith Securities Reminder Blog

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased the common stock of A.O. Smith Corporation (“AOS” or the “Company”) (NYSE: AOS) between July 26, 2016 through May 16, 2019, inclusive (the “Class Period”). [Read more…]

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

ADMS INVESTORS NOTICE: Lieff Cabraser Investigates Claims Against Adamas Pharmaceuticals, Inc.

Lieff Cabraser is investigating claims on behalf of investors of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (Nasdaq: ADMS), including investors who purchased Adamas common stock directly in the Company’s January 24, 2018 secondary public offering (“SPO”).

Adamas investors who wish to learn more about the investigation should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358. [Read more…]

AOS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against A.O. Smith Corporation

AOS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against A.O. Smith Corporation

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased the common stock of A.O. Smith Corporation (“A.O. Smith” or the “Company”) (NYSE: AOS) between July 26, 2016 through May 16, 2019, inclusive (the “Class Period”). [Read more…]

ADMS INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. Securities Blog

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased the common stock of Adamas Pharmaceuticals, Inc. (“Adamas” or the “Company”) (Nasdaq: ADMS) directly in the Company’s January 24, 2018 secondary public offering (“SPO”). [Read more…]

INVESTORS NOTICE: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Indivior PLC

Indivior Securities Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior PLC (“Indivior” or the “Company”) (OTC BB: INVVY) between March 10, 2015 and April 9, 2019, inclusive (the “Class Period”). [Read more…]

NTNX INVESTORS REMINDER: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Nutanix, Inc.

Nutanix Securities Final Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

INVVY INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Indivior PLC

Lieff Cabraser Announces Securities Class Action Against Indivior plc

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior PLC (“Indivior” or the “Company”) (INVVY) between March 10, 2015 and April 9, 2019, inclusive (the “Class Period”). If you purchased or otherwise acquired Indivior securities during the Class Period, you may move the Court for appointment as lead plaintiff by no later than June 24, 2019. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the actions will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the actions.

[Read more…]

NTNX INVESTORS Notice: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Nutanix, Inc.

Nutanix Securities Reminder

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

NTNX INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Nutanix, Inc.

Nutanix Securities

SAN FRANCISCO, CA – (April 12, 2019) – Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Nutanix, Inc. (“Nutanix” or the “Company”) (Nasdaq: NTNX) between March 2, 2018 and February 28, 2019, inclusive (the “Class Period”). [Read more…]

INGN INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Inogen, Inc.

Inogen Securities Blog

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Inogen, Inc. (“Inogen” or the “Company”) (Nasdaq: INGN) between November 8, 2017 and February 26, 2019, inclusive (the “Class Period”). [Read more…]